Cannabis licensing in Pennsylvania
Pennsylvania’s register lists 6 cannabis licenses, 6 reported active with no published expiry passed, covering medical license types across 1 categories.
* This reflects the stored source snapshot and is only as current and complete as that register. See the retrieval date and reconciliation notes below.
Who issues licenses in Pennsylvania
Licenses are published by Pennsylvania’s cannabis regulator. We read that register directly: www.pa.gov. Last retrieved .
This page describes what the register contains. It is not legal advice and does not state Pennsylvania’s cannabis law — for possession limits, residency rules or application requirements, go to the regulator.
What license types Pennsylvania issues
States name the same activity differently, which makes them hard to compare. Below is Pennsylvania’s own wording alongside the category it maps to here.
| Regulator’s wording | Category | Licenses |
|---|---|---|
| Approved Laboratory | Testing Laboratory | 6 |
Where licensed businesses are
Largest license holders in Pennsylvania
- 1ACT Laboratories of Pennsylvania LLC2 licenses
- 2Coral Reef Labs1 licenses
- 3Keystone State Testing LLC1 licenses
- 4Steep Hill Pennsylvania1 licenses
- 5US CANNALYTICS1 licenses
Research checked 22 September 2026. Every cited URL resolved on that date.
1. The regulator
The regulator is the Pennsylvania Department of Health, Bureau of Medical Marijuana (BMM). The Department redesignated its former Office of Medical Marijuana as the Bureau in January 2024; the Bureau administers the Medical Marijuana Act and regulates grower/processor and dispensary permits (2024 Biennial Report).
No consolidated public license register was verified. The Department publishes separate lists of dispensaries with product, Phase I grower/processors, Phase II grower/processors, and approved laboratories; together they remain incomplete as a permit dataset.
2. License types
Pennsylvania does not issue adult-use cannabis business licenses. Its statute authorises cannabis outside the medical programme only for the specific research schemes in Chapters 19 and 20 (Medical Marijuana Act, §§ 304, 601 and Chapters 19–20).
Grower/processor permit. It permits growing and processing medical marijuana and supplying permitted organisations as the Act allows. The original programme cap is 25 permits, but clinical-research permits and Act 63 permits sit outside that original allocation, so a current absolute cap is not verified (Medical Marijuana Act, §§ 601, 616–618 and 2002).
Dispensary permit. It permits dispensing medical marijuana to registered patients and caregivers. The original cap is 50 permits, ordinarily with up to three locations each; clinical registrants may have up to six locations, and Act 63 adds permits outside the original allocation. A current absolute cap is therefore not verified (Medical Marijuana Act, §§ 601, 616–618 and 2002).
Approved laboratory approval. A laboratory needs Department approval to test medical marijuana; approval is location-specific, lasts two years and is not transferable without prior written consent. No numerical cap was verified in the laboratory rules (28 Pa. Code Chapter 1171a, especially §§ 1171a.22–25).
Two research designations sit alongside them. A clinical registrant may hold both permits under a contract with an accredited medical school; the cap is ten (Medical Marijuana Act, §§ 2001–2002). An academic clinical research centre receives research certification, not a cultivation or retail license; ten are listed (Clinical Research). Chapter 19 also provides for health care medical marijuana organisation research approval; current issuances and a cap are not verified (Medical Marijuana Act, Chapter 19).
3. Market structure
The ordinary market is capped and competitively scored, not continuously open or a lottery. The last verified general window was Phase II, 5 April–17 May 2018, for up to 13 grower/processor and 23 dispensary permits; the highest-scoring qualified applications were selected (Pennsylvania Bulletin, 24 March 2018).
Act 63 created a narrow later route for an eligible independent grower/processor to obtain one dispensary permit and an eligible independent dispensary to obtain one grower/processor permit. It was not a reopening for general applicants. The Department records Phase 1 in autumn 2024, Phase 2 in spring 2025 and Phase 3 in autumn 2025 as closed; exact Phase 1 opening and closing dates are not verified (Act 63). The verified Phase 3 window ran from 1 to 31 October 2025 (Medical Marijuana Advisory Board presentation, 17 September 2025).
4. Who can apply
No Pennsylvania-residency requirement for an applicant, owner or financial backer was verified. Applicants must disclose principals, operators and backers, provide fingerprints and criminal-history checks, secure suitable Pennsylvania premises, and meet operational, security and financial requirements (Medical Marijuana Act, §§ 602–607).
One person may hold no more than five dispensary permits and, ordinarily, one grower/processor permit; limited statutory exceptions apply to clinical registrants and Act 63 recipients (Medical Marijuana Act, §§ 616–618 and 2002). Laboratory ownership and employment must remain independent from medical marijuana organisations that use the laboratory (28 Pa. Code § 1171a.22).
A principal, financial backer, operator or employee is barred for a felony related to manufacturing, delivering, or possessing with intent to manufacture or deliver a controlled substance, until at least ten years after final disposition or one year after release from imprisonment, whichever is later (Medical Marijuana Act, § 614).
No general social-equity license, reserved permit, scoring preference or fee waiver was verified. Applicants must submit a diversity plan and permittees must report equal-opportunity and contracting efforts at renewal; that is an outreach obligation, not a license award (28 Pa. Code § 1141a.32). Act 63 gives one limited benefit: during the first year after an added location becomes operational, its change-of-control restriction does not apply to a merger or acquisition involving a statutorily defined diverse group (Medical Marijuana Act, §§ 617–618).
5. Renewal
Grower/processor and dispensary permits last one year and renew annually (28 Pa. Code § 1141a.25). A renewal application and fee must arrive four to six months before expiry, with compliance, criminal-charge and diversion information; the Department may require supplements within 30 days (28 Pa. Code § 1141a.36).
Without a timely application and fee, the permit becomes invalid immediately on its expiry date and operations must stop. A timely filer may receive an administrative extension while the Department acts. Renewal may be denied for inadequate diversion control, falsification, or likely non-compliance (28 Pa. Code § 1141a.37). Laboratory approval lasts two years and its renewal is also filed four to six months before expiry; the precise effect of a late laboratory renewal is not verified (28 Pa. Code §§ 1171a.23–25).
6. Transfers
A permit cannot itself be sold, assigned or moved: it is a revocable privilege issued to the named person for the named location (28 Pa. Code §§ 1141a.25–26). A buyer can instead acquire equity or control of the permit-holding entity, but every incoming and outgoing principal, operator and financial backer must be reported with a $250 fee, and incoming individuals must submit the disclosures required of an initial applicant. Completing a transaction without the Department's knowledge is a violation (28 Pa. Code § 1141a.39).
The Department vets the suitability of new affiliates; it does not approve the commercial equity transaction itself (final-rule preamble, 4 March 2023). A premises move needs separate Department approval and an amended permit (Medical Marijuana Act, § 609). An Act 63 recipient generally may not change control for one year after its new location becomes operational, subject to the diverse-group exception described above (Medical Marijuana Act, §§ 617–618). A laboratory approval is transferable only with the Department's prior written consent (28 Pa. Code § 1171a.23).
7. Changed in the last 24 months
- Autumn 2024: the restricted Act 63 Phase 1 window opened and closed; exact dates and the number awarded are not verified (Act 63).
- By 16 April 2025: Phase 2 had received two applications, one was withdrawn and one permit was awarded (Medical Marijuana Advisory Board presentation, 16 April 2025).
- 1–31 October 2025: the restricted Act 63 Phase 3 application window ran and then closed (Medical Marijuana Advisory Board presentation, 17 September 2025; Act 63).
- 25 September 2025 and 28 April 2026: litigation over the two-laboratory testing rule was remanded and then placed on a merits schedule; the stay of § 1171a.29(c)(1)–(2) remained in effect (Medical Marijuana Regulations).
- 17 March 2026: the Commonwealth Court temporarily enjoined enforcement of part of the botanically derived terpene rule, § 1151a.27(f)(iii), while the case proceeds (Growers/Processors).
Sources
- https://www.pa.gov/agencies/health/programs/medical-marijuana/act-63
- https://www.pa.gov/agencies/health/programs/medical-marijuana/clinical-research
- https://www.pa.gov/agencies/health/programs/medical-marijuana/growers-processors
- https://www.pa.gov/agencies/health/programs/medical-marijuana/laboratories
- https://www.pa.gov/agencies/health/programs/medical-marijuana/medical-marijuana-regulations
- https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/medical-marijuana/June%2024%202026%20MMAB%20Program%20Update%20Data.pdf
- https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/medical-marijuana/Medical%20Marijuana%20Biennial%20Report%202024.pdf
- https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/medical-marijuana/Medical%20Marijuana%20Dispensaries%20in%20Pennsylvania%20with%20Product.pdf
- https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/medical-marijuana/MMAB%20Presentation%20April%2016%202025.pdf
- https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/medical-marijuana/MMAB%20Presentation%20%E2%80%93%20September%2017%2C%202025.pdf
- https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/medical-marijuana/PA%20DOH%20Phase%20II%20Grower-Processor%20Permittee%20Facility%20Locations%20by%20Region.pdf
- https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/medical-marijuana/phase-1/Phase%201%20Grower-Processor%20Permittee%20Facility%20Locations%20By%20Region.pdf
- https://www.legis.state.pa.us/WU01/LI/LI/US/PDF/2016/0/0016..PDF
- https://www.pacodeandbulletin.gov/secure/pabulletin/data/vol48/48-12/48-12.pdf
- https://www.pacodeandbulletin.gov/secure/pabulletin/data/vol53/53-9/314.html
- https://www.pacodeandbulletin.gov/secure/pacode/data/028/chapter1141a/s1141a.25.html
- https://www.pacodeandbulletin.gov/secure/pacode/data/028/chapter1141a/s1141a.26.html
- https://www.pacodeandbulletin.gov/secure/pacode/data/028/chapter1141a/s1141a.32.html
- https://www.pacodeandbulletin.gov/secure/pacode/data/028/chapter1141a/s1141a.36.html
- https://www.pacodeandbulletin.gov/secure/pacode/data/028/chapter1141a/s1141a.37.html
- https://www.pacodeandbulletin.gov/secure/pacode/data/028/chapter1141a/s1141a.39.html
- https://www.pacodeandbulletin.gov/secure/pacode/data/028/chapter1171a/chap1171atoc.html
Compiled from Pennsylvania’s regulator, statute and administrative code, with 22 sources cited inline. Regulation changes; check the linked source before relying on any specific figure.
Browse the Pennsylvania register
Covered Pennsylvania license records, searchable by type, status and city.
All 6 Pennsylvania licenses →